PMC · DOI:10.1016/j.jdcr.2023.09.037·October 15, 2023
Resolution of long standing hypergammaglobulinemic purpura of Waldenström after initiating treatment for cystic fibrosis with Elexacaftor–Tezacaftor–Ivacaftor
Kimberly Tantuco, Jennifer Beecker, Melanie Chin
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Genes2
Proteins2
Chemicals9
Diseases29
lung diseasemaculescoughhyperpigmentationinflammationhepatitis CinfectionspainarthritisPurpuraSjogren's antibodiesclubbingpurpuric rashautoimmune hepatitisedema of the feetPurpuric maculessputum productionsystemic lupus erythematosusFlaresCFpolyclonal gammopathyarthralgiadiedHGPWmultiple myelomalung infectionsreduced daily pulmonary symptomsshortness of breathmultisystem disorder
Mutations1
F508del
Figures3
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCystic Fibrosis Research Advances · Immunodeficiency and Autoimmune Disorders · Congenital Ear and Nasal Anomalies